Skip to main content

Advertisement

ADVERTISEMENT

videos

Videos
12/05/2019
Michael Williams, MD, discusses treatment approaches for a variety of patients with mantle cell lymphoma.
Michael Williams, MD, discusses treatment approaches for a variety of patients with mantle cell lymphoma.
Michael Williams, MD, discusses...
12/05/2019
Oncology
Videos
11/13/2019
Vincent Rajkumar, MD, explains treatment approaches for patients with newly-diagnosed MM ineligible for transplant.
Vincent Rajkumar, MD, explains treatment approaches for patients with newly-diagnosed MM ineligible for transplant.
Vincent Rajkumar, MD, explains...
11/13/2019
Oncology
Videos
11/13/2019
Thomas Kipps, MD, PhD, gives an update on the development of CAR T-cell therapy at the 2019 Lymphoma & Myeloma Congress.
Thomas Kipps, MD, PhD, gives an update on the development of CAR T-cell therapy at the 2019 Lymphoma & Myeloma Congress.
Thomas Kipps, MD, PhD, gives an...
11/13/2019
Oncology
Videos
11/13/2019
Jennifer Woyach, MD, discusses treatment options for older patients with CLL and why treating older patients differs from treating younger patients.
Jennifer Woyach, MD, discusses treatment options for older patients with CLL and why treating older patients differs from treating younger patients.
Jennifer Woyach, MD, discusses...
11/13/2019
Oncology
Videos
11/12/2019
Matthew S. Davids, MD, MMSc, discusses venetoclax resistance in CLL and how to manage patients resistant to the drug.
Matthew S. Davids, MD, MMSc, discusses venetoclax resistance in CLL and how to manage patients resistant to the drug.
Matthew S. Davids, MD, MMSc,...
11/12/2019
Oncology
Videos
11/12/2019
Craig Sauter, MD, explains which patients should receive CAR T-cells for DLBCL.
Craig Sauter, MD, explains which patients should receive CAR T-cells for DLBCL.
Craig Sauter, MD, explains which...
11/12/2019
Oncology
Videos
11/12/2019
Ajai Chari, MD, explains whether anti‑CS1, anti‑CD38, and bispecifics, should be used in the frontline setting for multiple myeloma.
Ajai Chari, MD, explains whether anti‑CS1, anti‑CD38, and bispecifics, should be used in the frontline setting for multiple myeloma.
Ajai Chari, MD, explains whether...
11/12/2019
Oncology
Videos
11/12/2019
Richard Furman, MD, explains how best to control CLL patients who progress on BTK inhibitor therapy.
Richard Furman, MD, explains how best to control CLL patients who progress on BTK inhibitor therapy.
Richard Furman, MD, explains how...
11/12/2019
Oncology
Videos
11/07/2019
Koen van Besien, MD, PhD, discusses data on the indications for transplant for patients with low and intermediate‑grade MDS.
Koen van Besien, MD, PhD, discusses data on the indications for transplant for patients with low and intermediate‑grade MDS.
Koen van Besien, MD, PhD,...
11/07/2019
Oncology
Videos
11/04/2019
Steven Treon, MD, PhD, FACP, FRCP, provided an update on the latest research in the treatment of Waldenström Macroglobulinemia.
Steven Treon, MD, PhD, FACP, FRCP, provided an update on the latest research in the treatment of Waldenström Macroglobulinemia.
Steven Treon, MD, PhD, FACP,...
11/04/2019
Oncology

Advertisement